#fda-regulations

#fda-regulations

FDA allowed compounding pharmacies a grace period to cease production post-drug shortage, but some continue to sell modified tirzepatide products.

Compounding pharmacies are suing the FDA to continue producing tirzepatide imitations despite the drug's supply improving.

The FDA announced that the tirzepatide shortage has been resolved, impacting compounding pharmacies' operations.

Obesity treatments are transforming patients' relationship with food but compounding alternatives to popular drugs face restrictions.

FDA's declaration ends availability of compounded tirzepatide, causing distress among patients who rely on it.

Federal food safety regulators warned Bimbo Bakeries USA for mislabeling allergens on their products, impacting 33 million Americans with food allergies.

U.S. health officials plan to phase out eight petroleum-based artificial colors from food, replacing them with natural substitutes.

RFK Jr.'s potential appointment could bring significant attention to food additive regulations and public health concerns.

Rizo Lopez Foods recalled products linked to a listeria outbreak that caused two deaths, leading to a federal court injunction against its operations.

The FDA has updated the definition of 'healthy' for packaged foods, aiming to improve consumer choices and public health.

High-quality protein powder may be beneficial but is not necessary for everyone.

Many fruit snacks contain minimal real fruit, misleading consumers about their nutritional value.

Consumers deserve to easily understand food's nutritional value for informed decisions, particularly for ingredients like sugar.

Sunscreen innovation is hindered in the U.S. due to strict FDA regulations compared to other countries that approve new filters more readily.

Sunscreen is essential for skin health and safety, reducing the risk of skin cancer and premature aging.

The Super Bowl ad for Hims & Hers is under scrutiny for lacking mandatory disclosures required for pharmaceutical ads.

Mammography facilities must notify patients about breast density to enhance early breast cancer detection starting Sep. 10, 2024.

Compounded tirzepatide offers immediate weight-loss benefits but will soon be unavailable due to FDA restrictions.

The FDA mandates GSK and Pfizer to include GBS risk warnings on their RSV vaccines due to safety concerns after an observational study.

FDA updates 'healthy' food labeling to reflect current nutrition standards

New rules aim to empower consumers to find nutritious food easily

The definition of healthy now includes processed foods and previously excluded items

The FDA plans to drastically reduce nicotine levels in cigarettes to prevent addiction and reduce smoking-related deaths.

Valisure, a tiny laboratory in Connecticut, has detected harmful chemicals in widely used medications, leading to product recalls and increased awareness of product safety issues.

RFK Jr. could significantly influence health policy if confirmed, but complicated bureaucratic structures may hinder his initiatives.

Legal challenges may arise against proposals for stricter regulations or bans on pharmaceutical advertisements due to First Amendment protections.

Concerns are raised about the impact of Robert Kennedy's policies on drug approval standards at the FDA.

Dense breast tissue significantly increases cancer risk, yet women often lack guidance on their diagnosis and next steps.

Recent FDA regulations will improve communication regarding breast density following mammograms.

Breast density can obscure cancer detection in mammograms, prompting the need for updated screening guidelines and communication about risks.

The surge in compounded GLP-1 drugs addresses availability but leads to regulatory issues and legal battles.

Compounding offers personalized medication options, even amidst drug shortages.

The obscurity of a federal statute is enabling US pharmacies to flood the market with unvetted knockoffs of popular weight-loss drug Ozempic.

The U.S. Supreme Court's decision prevents restrictions on nationwide access to the abortion pill mifepristone, but concerns persist over medication abortion access and FDA regulations.

The U.S. Supreme Court may change how the FDA interacts with regulated industries based on decisions regarding monitoring costs for fishing vessels.

The U.S. Supreme Court will review the FDA's rejection of marketing new flavored vaping products, questioning FDA's decision-making process under the Family Smoking Prevention and Tobacco Control Act.

The FDA's 1938 law hampers the approval process for better, more effective sunscreen ingredients, blocking Americans from access to superior sun protection.

Americans may not have access to advanced sunscreens due to outdated FDA regulations.

The Supreme Court issued decisions upholding abortion access in recent cases, rejecting challenges to FDA's changes and clarifying conflicts between state and federal laws.